Baptist Health Lexington-Research ( Site 2502) — Lexington, Kentucky

Baptist Health Lexington-Research ( Site 2502) is a clinical research site located in Lexington, Kentucky, United States 40503.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Baptist Health Lexington-Research ( Site 2502) has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non Small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baptist Health Lexington-Research ( Site 2502)?

Baptist Health Lexington-Research ( Site 2502) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baptist Health Lexington-Research ( Site 2502) conducted?

Baptist Health Lexington-Research ( Site 2502) has 1 clinical trials on record. Their work covers Metastatic Non Small Cell Lung Cancer.

Is Baptist Health Lexington-Research ( Site 2502) accredited by Crixeo Health?

Baptist Health Lexington-Research ( Site 2502) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baptist Health Lexington-Research ( Site 2502)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.